October 27, 2025 · Form 4 insider transaction
Rowland Charles A Jr sold 60,000 shares of Viking Therapeutics, Inc. at $35.57 per share, a transaction worth $2.13M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.02 to $35.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.